NCT05368467 National Registry and Cohort Study of Pulmonary Vascular Disease
| NCT ID | NCT05368467 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Condition | Pulmonary Arterial Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-03-29 |
| Primary Completion | 2028-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2022-03-29 with a primary completion date of 2028-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH；also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed or previously diagnosed patients with PH. * Documentation of mean pulmonary arterial pressure (mPAP) \>20 mm Hg by right heart catheterization, performed at any time prior to study enrollment. Exclusion Criteria: * Have not had documentation of hemodynamic criteria for PH by right heart catheterization at some time preceding study entry and following development of symptoms associated with PH. * Do not meet the required hemodynamic criteria for entry into the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05368467 clinical trial?
This trial is open to participants of all sexes, studying Pulmonary Arterial Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05368467 currently recruiting?
Yes, NCT05368467 is actively recruiting participants. Contact the research team at chmengx@126.com for enrollment information.
Where is the NCT05368467 trial being conducted?
This trial is being conducted at Guangzhou, China, Nanjing, China, Tianjin, China, Beijing, China and 9 additional locations.
Who is sponsoring the NCT05368467 clinical trial?
NCT05368467 is sponsored by Nanjing First Hospital, Nanjing Medical University. The trial plans to enroll 1,000 participants.